Who owns CONTEXT THERAPEUTICS INC COM?
- Ticker: CNTX
- CUSIP Number: 21077p108
Tip: Access positions for across all investors
Analyze quarterly positions in Context Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Context Therapeutics stock
Who bought or sold CONTEXT THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deep Track Capital | 7.4M | $15M | 100% | Jun 2024 |
|
| Nextech Invest | 7.4M | $15M | 0% | Sep 2024 |
|
| Avidity Partners Management | 7.4M | $15M | 0% | Sep 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 6.9M | $14M | -7% | Sep 2024 |
|
| Blue Owl Capital Holdings | 5.4M | $11M | 5% | Sep 2024 |
|
| Vanguard Group | 4.5M | $9.0M | 652% | Jun 2024 |
|
| Blackstone Group | 2.4M | $4.8M | 33% | Sep 2024 |
|
| Nantahala Capital Management | 1.9M | $3.8M | 0% | Sep 2024 |
|
| Franklin Resources | 1.9M | $3.7M | 100% | Sep 2024 |
|
| Alyeska Investment Group | 1.7M | $3.3M | -14% | Sep 2024 |
|
| Woodline Partners | 1.4M | $2.7M | 100% | Sep 2024 |
|
| Sio Capital Management | 1.3M | $2.7M | 100% | Jun 2024 |
|
| Affinity Asset Advisors | 1.3M | $2.6M | -18% | Sep 2024 |
|
| BlackRock | 852k | $1.7M | 100% | Jun 2024 |
|
| BlackRock | 849k | $1.7M | 100% | Sep 2024 |
|
| Geode Capital Management | 576k | $1.1M | -7% | Sep 2024 |
|
| Altium Capital Management | 360k | $722k | 100% | Jun 2024 |
|
| Northern Trust | 173k | $338k | 364% | Sep 2024 |
|
| HighTower Advisors | 126k | $252k | 0% | Jun 2024 |
|
| Mill Creek Capital Advisors | 105k | $205k | 0% | Sep 2024 |
|
| State Street Corporation | 92k | $185k | 180% | Jun 2024 |
|
| Renaissance Technologies | 66k | $129k | 1% | Sep 2024 |
|
| Susquehanna International | 54k | $106k | 100% | Sep 2024 |
|
| Y-Intercept | 46k | $89k | 100% | Sep 2024 |
|
| Citigroup | 45k | $88k | 100% | Sep 2024 |
|
| Bridgeway Capital Management | 42k | $83k | -61% | Jun 2024 |
|
| Clear Harbor Asset Management | 36k | $71k | 0% | Sep 2024 |
|
| Verition Fund Management | 16k | $33k | 100% | Jun 2024 |
|
| Two Sigma Investments | 14k | $28k | 100% | Jun 2024 |
|
| Bank of America Corporation | 10k | $20k | -5% | Sep 2024 |
|
| HPM Partners | 10k | $20k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 500.00 | $980.000000 | -67% | Sep 2024 |
|
| AdvisorNet Financial | 200.00 | $392.000000 | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 173.00 | $338.993500 | 100% | Sep 2024 |
|
Who sold out of Context Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Driehaus Capital Management | Jun 2024 | 2.3M | $4.5M |
| Leucadia National Corporation | Mar 2024 | 12k | $16k |
| Tower Research Capital | Mar 2024 | 6.4k | $8.8k |
| Federation des caisses Desjardins du Quebec | Jun 2024 | 400.00 | $802.000000 |